http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2014146977-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y302-01035 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-737 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-735 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-136 |
| filingDate | 2014-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2014146977-A |
| titleOfInvention | NEW MEDICINES FOR LOCAL USE ON THE BASIS OF SULPHATED HYALURONIC ACID AS STIMULATORS OR INHIBITORS OF CYTOKINE ACTIVITY |
| abstract | 1. Sulfated hyaluronic acid for topical use for the prevention and / or treatment of herpes simplex of the lips and genitals, vesicular stomatitis virus and cytomegalovirus, wherein said sulfated hyaluronic acid (HA) has a molecular weight in the range from 10,000 to 50,000 Yes, from 150,000 to 250,000 Yes, or from 500,000 to 750,000 Yes, and the degree of sulfation equal to 1 or 3.2. A topical pharmaceutical composition containing sulfated hyaluronic acid according to claim 1, possibly together with pharmacologically and / or biologically active agents. The pharmaceutical composition according to claim 2, containing steroids, hormones, proteins, trophic factors, vitamins, non-steroidal anti-inflammatory drugs, topical chemotherapeutic drugs, antibiotics, antiviral agents, local anesthetics, anticoagulants and / or fibrinolytic agents, enzymes and / or other proteases. 4. The pharmaceutical composition of claim 3, further comprising polymers such as hyaluronic acid and its derivatives, carboxymethyl cellulose and / or other polymers of natural or synthetic origin. The pharmaceutical composition according to PP. 2-4 in the form of ointment, lipogel, hydrogel, lipstick, cream, plasters, vaginal suppositories and suppositories, foam, gel for application to mucous membranes, ophthalmic preparations, compositions for washing the vagina, rinsing for the oral cavity, solutions for local application or inhalation .6. The pharmaceutical composition according to claim 5, containing sulfated hyaluronic acid as a stimulator of skin absorption of drugs in the form of ointments, lipogels, |
| priorityDate | 2009-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450770914 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663392 |
Total number of triples: 38.